Feedback / Questions
foralumab nasal (TZLS-401 nasal) - Tiziana Life Sci
https://www.globenewswire.com/news-release/2025/04/23/3066234/0/en/Tiziana-Life-Sciences-Announces-University-of-Massachusetts-Commences-Dosing-Intranasal-Foralumab-in-Phase-2-Multiple-Sclerosis-Trial.html
Apr 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next